Han desarrollado una calculadora que identifica los pacientes con mieloma múltiple y amiloidosis sistémica primaria que presentan mejor pronóstico al tener un perfil más benigno.
Read moreEl Instituto de Investigación Sanitaria INCLIVA ha puesto en marcha un ensayo clínico sobre salud ósea de pacientes de cáncer de mama, en el marco del proyecto europeo REBECCA.
Read moreLa detección precoz en pacientes con trastornos psicóticos es crucial para poder diagnosticarlos, tratarlos, y mejorar su pronóstico. Los resultados de un estudio enfatizan que las manifestaciones ...
Read moreThe HIPRA vaccine against COVID-19 is the first vaccine authorised for human health that has been designed and developed in Spain, and various services and units from both the Hospital Clínic Barcelo...
Read moreThe results open the possibility of using 5 genes identified as markers that correlate with the severity of the disease in the brain
Read moreThe Institut de Recerca Sant Joan de Déu (IRSJD) participates in XarSMART, a project that aims to promote the generation of medical technologies and new companies in Catalonia in the field of life sc...
Read moreResearchers are leading a pioneering study that aims to determine whether a blood test can provide information about the brain of people with neurological dysfunctions like autism. This test would ena...
Read moreGenerating new memories and remembering are two sides of the same coin, although sometimes they can appear as separate mechanisms. These mechanisms which seem to be distanced from each other are actua...
Read moreA study in which IDIBAPS researchers took part has found new alterations that cause loss of function in the BMPR2 gene, leading to uncontrolled proliferation of the epithelial cells of the colon and a...
Read more3P Biopharmaceuticals and the American biotech company, Zhittya Genesis Medicine (Zhittya), have successfully accomplished the process transfer and GMP supply of FGF-1 candidate.
Read moreThey have evaluated the efficacy of soluble low-density lipoprotein receptor 1 (sLRP1) as an indicator of carotid plaque inflammation.
Read moreD-Sight ha recibido un millón de euros de inversión por parte del fondo de capital riesgo Clave Capital para desarrollar nuevas estrategias terapéuticas innovadoras para el tratamiento de la retino...
Read more